glp 1 osa glp-1 approved for sleep apnea Did You Know? The FDA has approved GLP-1 treatments for moderate to severe obstructive sleep apnea (OSA) in adults with obesity. This breakthrough provides a new GLP-1 Medications Show Promise as

10.3390/jcm8111814 80 JakubowskaA.RouxC

Heightened response of eosinophilic asthmatic patients to the CRTH 2 antagonist OC 000459

For established cognitive support, the evidence-based options include aerobic exercise (strong evidence for cognitive benefits, especially executive function and processing speed), sleep optimization (critical for cognitive function), Mediterranean diet (modest evidence for cognitive protection over years), treating sleep apnea (significant cognitive improvements when this condition is addressed), treating depression (major cognitive effects when present), donepezil and other approved Alzheimer drugs (modest evidence-based effects in actual Alzheimer disease), and stimulants (well-established for ADHD)

Clinical trials back its use in reducing belly fat and it may aid in overall body contouring ahead of surgery

Persistent microbiome alterations modulate the rate of post-dieting weight regain (in Eng)